These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18639901)

  • 41. Re: Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance K. Fujika, P. Landis, B. K. McNeil and C. P. Pavlovich J Urol 2009; 182: 2664-2669.
    Atan A; Tuncel A
    J Urol; 2010 Jun; 183(6):2471-2. PubMed ID: 20416896
    [No Abstract]   [Full Text] [Related]  

  • 42. BiopSym: a simulator for enhanced learning of ultrasound-guided prostate biopsy.
    Sclaverano S; Chevreau G; Vadcard L; Mozer P; Troccaz J
    Stud Health Technol Inform; 2009; 142():301-6. PubMed ID: 19377173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.
    Lattouf JB; Grubb RL; Lee SJ; Bjurlin MA; Albert P; Singh AK; Ocak I; Choyke P; Coleman JA
    BJU Int; 2007 May; 99(5):1041-6. PubMed ID: 17437438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy.
    Narayanan R; Werahera PN; Barqawi A; Crawford ED; Shinohara K; Simoneau AR; Suri JS
    Phys Med Biol; 2008 Oct; 53(20):N397-406. PubMed ID: 18827317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast enhanced ultrasound of the prostate. New role in the evaluation of loco-regional therapy of prostate tumors.
    Sparchez Z
    Med Ultrason; 2018 May; 20(2):125-126. PubMed ID: 29730675
    [No Abstract]   [Full Text] [Related]  

  • 46. Re: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies: R. Abouassaly, N. Tan, A. Moussa and J. S. Jones J Urol 2008; 180: 911-914.
    Feldstein MS; Hentz JG
    J Urol; 2009 Apr; 181(4):1960-1; author reply 1961. PubMed ID: 19251278
    [No Abstract]   [Full Text] [Related]  

  • 47. [Role of expectant therapy in prostatic carcinoma of low grade and staging].
    Lorusso A; Curatolo C; Giocoli Nacci G; Ludovico GM; Cirillo Limitone DA; Marucco EC; Pagliarulo A
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):155-7. PubMed ID: 9162350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of prostate biopsies in a teaching hospital in Western Saudi Arabia.
    Tayib AM; Mosli HA; Al-Ammari AA
    Saudi Med J; 2003 Aug; 24(8):859-62. PubMed ID: 12939672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The diagnosis, biopsy and treatment follow-up via ultrasound in patients with prostatic carcinoma].
    Mladenov D; Tsvetkov M; Kumanov Kh
    Khirurgiia (Sofiia); 1991; 44(5):18-20. PubMed ID: 1844458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ultrasonography-guided transperineal prostatic biopsy: optimization of sampling protocol after 1,352 biopsies].
    Romagnoli A; Giglio M; Timossi L; Bertolotto F; Germinale F; Carmignani G
    Arch Ital Urol Androl; 2002 Dec; 74(4):285-9. PubMed ID: 12508753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Editorial comment.
    Ukimura O
    J Urol; 2013 Jan; 189(1):91-2. PubMed ID: 23158415
    [No Abstract]   [Full Text] [Related]  

  • 52. Re: Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?: A. Walton Diaz, A. N. Hoang, B. Turkbey, C. W. Hong, H. Truong, T. Sterling, S. Rais-bahrami, M. M. Siddiqui, L. Stamatakis, S. Vourganti, J. Nix, J. Logan, C. Harris, M. Weintraub, C. Chua, M. J. Merino, P. Choyke, B. J. Wood and P. A. Pinto J Urol 2013; 190: 2020-2025.
    Goel MC
    J Urol; 2015 Apr; 193(4):1444-6. PubMed ID: 25582380
    [No Abstract]   [Full Text] [Related]  

  • 53. Editorial comment.
    Wood BJ; Choyke P; Turkbey B; Pinto P
    J Urol; 2013 Jan; 189(1):92. PubMed ID: 23158414
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial comment on: contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project.
    Singh AK
    Eur Urol; 2008 Nov; 54(5):993. PubMed ID: 18584940
    [No Abstract]   [Full Text] [Related]  

  • 55. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
    Singh I; Gautam L
    J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834.
    Ravi P; Sammon J; Meskawi M; Sun M; Karakiewicz PI; Trinh QD
    J Urol; 2012 Aug; 188(2):677-8. PubMed ID: 22704450
    [No Abstract]   [Full Text] [Related]  

  • 57. Novel Technique of Non-Intravenous Use of Ultrasound Contrast Media for Biopsy Needle Visualization.
    Chandrashekhara SH; Nair AD; Dhamija E; Kumar M
    Cardiovasc Intervent Radiol; 2022 Jul; 45(7):1039-1040. PubMed ID: 35419630
    [No Abstract]   [Full Text] [Related]  

  • 58. Re: A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. T. Wolters, M. J. Roobol, P. J. van Leeuwen, R. C. van den Bergh, R. F. Hoedemaeker, G. J. van Leenders, F. H. Schröder and T. H. van der Kwast. J Urol 2011;185: 121-125.
    Moore CM; Klotz L; Emberton M
    J Urol; 2011 Sep; 186(3):1158-9; author reply 1159. PubMed ID: 21784490
    [No Abstract]   [Full Text] [Related]  

  • 59. Re: Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study: L. C. Macleod, W. J. Ellis, L. F. Newcomb, Y. Zheng, J. D. Brooks, P. R. Carroll, M. E. Gleave, R. S. Lance, P. S. Nelson, I. M. Thompson, Jr., A. A. Wagner, J. T. Wei and D. W. Lin J Urol 2017;197:1026-1033.
    Denize J; Nouhaud FX; Cornu JN; Pfister C
    J Urol; 2017 Sep; 198(3):709-711. PubMed ID: 28579000
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: Small prostate size and high grade disease--biology or artifact?: J. J. Liu, J. D. Brooks, M. Ferrari, R. Nolley and J. C. Presti, Jr. J Urol 2011; 185: 2108-2111.
    Calışkan S
    J Urol; 2011 Dec; 186(6):2504; author reply 2504-5. PubMed ID: 22019038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.